FDA stalled on CBD for now: Analyst By: MarketWatch June 15, 2022 at 10:33 AM EDT FDA expresses interest in more studies of CBD but no real action is expected without a push from Congress, according to Cowen analyst. Read More >> Related Stocks: Jazz Pharma Plc
